IPL-423088

N/A

Report date: 2023/02/18 23:49:10

Base Information

Drug NameIPL-423088
Drug Alias NameIPL-4088
ClassificationOther
Mechanisms of ActionFibroblast growth factor receptor 4 antagonistsPhosphodieterase 4 inhibitors
TargetsFibroblast growth factor receptor 4Phosphodieterase 4
Therapy Area/IndicationsAsthmaInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInflazyme Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInflazyme Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAsthmaInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A